A clinical trial to learn about the effects of JFI447 and how it shows up in scans compared to FFG233 in people with solid tumors

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 22
• 2 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with certain metastatic solid tumors. It compares how JFI447 and FFG233 show up in scans.

Age

18 years or older

Sex

All sexes can join.

Disease stage

Metastatic cancer: pancreatic ductal cancer (PDAC), non-small cell lung cancer (NSCLC), HR+/HER2- ductal and lobular breast cancer, triple-negative breast cancer (TNBC), colorectal cancer (CRC) or soft tissue sarcoma (STS).

Main reasons for not taking part

• Healthy volunteers cannot join.

Read by machine on 9 Nov 2026.

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details